secwatch.observer — SEC 8-K summary
======================================

Issuer:     BELLICUM PHARMACEUTICALS, INC (—)
CIK:        0001358403
Form:       8-K
Filed at:   2024-01-24T23:59:59+00:00
Accession:  0001539497-24-000104
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellicum adjourns asset-sale special meeting for lack of quorum; issues super-voting share to director
--------------------------------------------------------------------------------

- Special meeting to approve sale of assets (CaspaCIDe, iMC, GoCAR-T, Rimiducid) to MD Anderson and dissolution adjourned; only 4,132,740 shares present, short of quorum.
- Issued one super-voting share to director Richard A. Fair for $0.01; holder casts votes proportionate to common stock votes at adjourned meeting.
- Bylaws amended: quorum now requires majority of voting power present, not majority of outstanding shares.
- No financial terms of asset sale disclosed; dissolution plan contingent on stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1358403/000153949724000104/0001539497-24-000104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1358403/000153949724000104/n3936_x2-8k.htm
  HTML page:      https://secwatch.observer/filing/0001539497-24-000104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer